The present study investigated the potential correlation between methylation levels in the promoter of the ACE2 gene and the development of long-lasting post-COVID-19 pain symptoms over one-and-a-half years in patients who need hospitalization due to COVID-19 during the first wave of the pandemic. The gene discussed is ACE2; the disease is COVID-19.